Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 479354, 11 pages
http://dx.doi.org/10.1155/2015/479354
Review Article

Insulin Resistance and Skin Diseases

Section of Dermatology, Department of Medicina Clinica e Chirurgia, University Federico II, Napoli, Italy

Received 18 February 2015; Accepted 17 March 2015

Academic Editor: Uwe Wollina

Copyright © 2015 Maddalena Napolitano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. G. Franks Jr., “Skin manifestations of internal disease,” Medical Clinics of North America, vol. 93, no. 6, pp. 1265–1282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Rigopoulos, G. Larios, and A. Katsambas, “Skin signs of systemic diseases,” Clinics in Dermatology, vol. 29, no. 5, pp. 531–540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Buerger, B. Richter, K. Woth et al., “Interleukin-1Β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis,” Journal of Investigative Dermatology, vol. 132, no. 9, pp. 2206–2214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Taniguchi, B. Emanuelli, and C. R. Kahn, “Critical nodes in signalling pathways: insights into insulin action,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 85–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Karadag, D. T. Ertugrul, S. Gunes Bilgili, Z. Takci, E. Tutal, and H. Yilmaz, “Insulin resistance is increased in alopecia areata patients,” Cutaneous and Ocular Toxicology, vol. 32, no. 2, pp. 102–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. H. G. de Moura, D. L. M. Costa, E. Bagatin, C. T. Sodré, and M. Manela-Azulay, “Polycystic ovary syndrome: a dermatologic approach,” Anais Brasileiros de Dermatologia, vol. 86, no. 1, pp. 111–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Carmina, F. Rosato, A. Jannì, M. Rizzo, and R. A. Longo, “Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 1, pp. 2–6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Ehrmann, “Polycystic ovary syndrome,” The New England Journal of Medicine, vol. 352, no. 12, pp. 1223–1236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Okita, H. Iwahashi, J. Kozawa et al., “Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy,” Endocrine Journal, vol. 60, no. 3, pp. 283–290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  11. T. M. Wallace, J. C. Levy, and D. R. Matthews, “Use and abuse of HOMA modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Katz, S. S. Nambi, K. Mather et al., “Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 7, pp. 2402–2410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. Sarafidis, A. N. Lasaridis, P. M. Nilsson et al., “Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes,” Journal of Human Hypertension, vol. 21, no. 9, pp. 709–716, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Antuna-Puente, M. Faraj, A. D. Karelis et al., “HOMA or QUICKI: is it useful to test the reproducibility of formulas?” Diabetes & Metabolism, vol. 34, no. 3, pp. 294–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Hud Jr., J. B. Cohen, J. M. Wagner, and P. D. Cruz Jr., “Prevalence and significance of acanthosis nigricans in an adult obese population,” Archives of Dermatology, vol. 128, no. 7, pp. 941–944, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Y. Nam, E. J. Lee, K. R. Kim et al., “Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone,” International Journal of Obesity, vol. 21, no. 5, pp. 355–359, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Siddle, B. Ursø, C. A. Niesler et al., “Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors,” Biochemical Society Transactions, vol. 29, no. 4, pp. 513–525, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Rudman, M. P. Philpott, G. A. Thomas, and T. Kealey, “The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?” Journal of Investigative Dermatology, vol. 109, no. 6, pp. 770–777, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Phiske, “An approach to acanthosis nigricans,” Indian Dermatology Online Journal, vol. 5, no. 3, pp. 239–249, 2014. View at Publisher · View at Google Scholar
  20. G. Yosipovitch, A. DeVore, and A. Dawn, “Obesity and the skin: skin physiology and skin manifestations of obesity,” Journal of the American Academy of Dermatology, vol. 56, no. 6, pp. 901–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. O. Curth, “Classification of acanthosis nigricans,” International Journal of Dermatology, vol. 15, no. 8, pp. 592–593, 1976. View at Publisher · View at Google Scholar · View at Scopus
  22. R. A. Schwartz, “Acanthosis nigricans,” Journal of the American Academy of Dermatology, vol. 31, no. 1, pp. 1–19, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. J. P. Burke, D. E. Hale, H. P. Hazuda, and M. P. Stern, “A quantitative scale of acanthosis nigricans,” Diabetes Care, vol. 22, no. 10, pp. 1655–1659, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kapoor, “Diagnosis and treatment of Acanthosis nigricans,” Skinmed, vol. 8, no. 3, pp. 161–165, 2010. View at Google Scholar · View at Scopus
  25. A. Zayed, R. M. Sobhi, and D. M. Abdel Halim, “Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study,” Journal of Dermatological Treatment, vol. 25, no. 3, pp. 223–225, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. B. C. Melnik and G. Schmitz, “Metformin: an inhibitor of mTORC1 signaling,” Journal of Endocrinology, Diabetes & Obesity, vol. 2, no. 2, p. 1029, 2014. View at Google Scholar
  27. T. Hermanns-Lê, A. Scheen, and G. E. Piérard, “Acanthosis nigricans associated with insulin resistance: pathophysiology and management,” American Journal of Clinical Dermatology, vol. 5, no. 3, pp. 199–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Del Prete, M. C. Mauriello, A. Faggiano et al., “Insulin resistance and acne: a new risk factor for men?” Endocrine, vol. 42, no. 3, pp. 555–560, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Titus and J. Hodge, “Diagnosis and treatment of acne,” American Family Physician, vol. 86, no. 8, pp. 734–740, 2012. View at Google Scholar · View at Scopus
  30. H. P. M. Gollnick, A. Y. Finlay, and N. Shear, “Can we define acne as a chronic disease? If so, how and when?” The American Journal of Clinical Dermatology, vol. 9, no. 5, pp. 279–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Chen, B. Obermayer-Pietsch, J.-B. Hong et al., “Acne-associated syndromes: models for better understanding of acne pathogenesis,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 6, pp. 637–646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. C. Zouboulis, “Acne as a chronic systemic disease,” Clinics in Dermatology, vol. 32, no. 3, pp. 389–396, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Borgia, S. Cannavò, F. Guarneri, S. P. Cannavò, M. Vaccaro, and B. Guarneri, “Correlation between endocrinological parameters and acne severity in adult women,” Acta Dermato-Venereologica, vol. 84, no. 3, pp. 201–204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Timpatanapong and A. Rojanasakul, “Hormonalprofiles and prevalence of polycystic ovary syndrome in women with acne,” Journal of Dermatology, vol. 24, no. 4, pp. 223–229, 1997. View at Google Scholar · View at Scopus
  35. R. Azziz, “Diagnostic criteria for polycystic ovary syndrome: a reappraisal,” Fertility and Sterility, vol. 83, no. 5, pp. 1343–1346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Housman and R. V. Reynolds, “Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations,” Journal of the American Academy of Dermatology, vol. 71, no. 5, pp. 847.e1–847.e10, 2014. View at Publisher · View at Google Scholar
  37. S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight, “Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems,” Endocrine Reviews, vol. 24, no. 6, pp. 737–764, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. K. Arora, A. Yadav, and V. Saini, “Role of hormones in acne vulgaris,” Clinical Biochemistry, vol. 44, no. 13, pp. 1035–1040, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Kumari and D. Thappa, “Role of insulin resistance and diet in acne,” Indian Journal of Dermatology, Venereology and Leprology, vol. 79, no. 3, pp. 291–299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Klinger, S. Anin, A. Silbergeld, R. Eshet, and Z. Laron, “Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome,” Clinical Endocrinology, vol. 48, no. 1, pp. 81–87, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Cordain, S. Lindeberg, M. Hurtado, K. Hill, S. B. Eaton, and J. Brand-Miller, “Acne vulgaris: a disease of western civilization,” Archives of Dermatology, vol. 138, no. 12, pp. 1584–1590, 2002. View at Google Scholar · View at Scopus
  42. R. N. Smith, N. J. Mann, A. Braue, H. Mäkeläinen, and G. A. Varigos, “The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial,” Journal of the American Academy of Dermatology, vol. 57, no. 2, pp. 247–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. B. C. Melnik, “Evidence for acne-promoting effects of milk and other insulinotropic dairy products,” Nestle Nutrition Workshop Series: Pediatric Program, vol. 67, pp. 131–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. B. C. Melnik, “Diet in acne: further evidence for the role of nutrient signalling in acne pathogenesis,” Acta Dermato-Venereologica, vol. 92, no. 3, pp. 228–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Adebamowo, D. Spiegelman, C. S. Berkey et al., “Milk consumption and acne in adolescent girls,” Dermatology Online Journal, vol. 12, no. 4, article 1, 2006. View at Google Scholar · View at Scopus
  46. C. A. Adebamowo, D. Spiegelman, C. S. Berkey et al., “Milk consumption and acne in teenaged boys,” Journal of the American Academy of Dermatology, vol. 58, no. 5, pp. 787–793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Melnik, “The pathogenic role of persistent milk signaling in mTORC1- and milk- microRNA-driven type 2 diabetes mellitus,” Current Diabetes Reviews, vol. 11, no. 1, pp. 46–62, 2015. View at Publisher · View at Google Scholar
  48. B. Demir, H. Ucak, D. Cicek, S. Aydin, I. Erden, and S. B. Dertlioglu, “Changes in serum desnutrin levels in patients with acne vulgaris,” European Journal of Dermatology, vol. 24, no. 5, pp. 589–593, 2014. View at Publisher · View at Google Scholar
  49. B. C. Melnik, S. M. John, and G. Plewig, “Acne: risk indicator for increased body mass index and insulin resistance,” Acta Dermato-Venereologica, vol. 93, no. 6, pp. 644–649, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Lindeberg, M. Eliasson, B. Lindahl, and B. Ahrén, “Low serum insulin in traditional Pacific Islanders—the Kitava study,” Metabolism, vol. 48, no. 10, pp. 1216–1219, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. B. C. Melnik, S. M. John, and G. Schmitz, “Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndrome,” Nutrition & Metabolism, vol. 8, article 41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. B. C. Melnik, “Dietary intervention in acne: attenuation of increased mTORC1 signaling promoted by Western diet,” Dermato-Endocrinology, vol. 4, no. 1, pp. 20–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Norat, L. Dossus, S. Rinaldi et al., “Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women,” European Journal of Clinical Nutrition, vol. 61, no. 1, pp. 91–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. F. L. Crowe, T. J. Key, N. E. Allen et al., “The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European prospective investigation into cancer and nutrition,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 5, pp. 1333–1340, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. C. A. Adebamowo, D. Spiegelman, F. W. Danby, A. L. Frazier, W. C. Willett, and M. D. Holmes, “High school dietary dairy intake and teenage acne,” Journal of the American Academy of Dermatology, vol. 52, no. 2, pp. 207–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. J. P. Leeming, K. T. Holland, and W. J. Cuncliffe, “The microbial colonization of inflamed acne vulgaris lesions,” British Journal of Dermatology, vol. 118, no. 2, pp. 203–208, 1988. View at Publisher · View at Google Scholar · View at Scopus
  57. R. N. Smith, N. J. Mann, A. Braue, H. Mäkeläinen, and G. A. Varigos, “A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial,” The American Journal of Clinical Nutrition, vol. 86, no. 1, pp. 107–115, 2007. View at Google Scholar · View at Scopus
  58. H. H. Kwon, J. Y. Yoon, J. S. Hong, J. Jung, M. S. Park, and D. H. Suh, “Clinical and histological effect of a low glycaemic load diet in treatment of acne vulgaris in Korean patients: a randomized, controlled trial,” Acta Dermato-Venereologica, vol. 92, no. 3, pp. 241–246, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. B. C. Melnik and C. C. Zouboulis, “Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne,” Experimental Dermatology, vol. 22, no. 5, pp. 311–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. B. C. Melnik, “The role of transcription factor FoxO1 in the pathogenesis of acne vulgaris and the mode of isotretinoin action,” Giornale Italiano di Dermatologia e Venereologia, vol. 145, no. 5, pp. 559–571, 2010. View at Google Scholar · View at Scopus
  61. A. Balato, L. Di Costanzo, C. Patruno, F. Ayala, M. Megna, and N. Balato, “Psoriasis or ‘psoriases’?” Giornale Italiano di Dermatologia e Venereologia, vol. 148, no. 6, pp. 649–650, 2013. View at Google Scholar
  62. C. E. Griffiths and J. N. Barker, “Pathogenesis and clinical features of psoriasis,” The Lancet, vol. 370, no. 9583, pp. 263–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. B. B. Davidovici, N. Sattar, P. C. Jörg et al., “Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions,” Journal of Investigative Dermatology, vol. 130, no. 7, pp. 1785–1796, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Naldi, L. Chatenoud, D. Linder et al., “Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study,” Journal of Investigative Dermatology, vol. 125, no. 1, pp. 61–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Barrea, N. Balato, C. Di Somma et al., “Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet?” Journal of Translational Medicine, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  66. N. Balato, M. Megna, F. Palmisano et al., “Psoriasis and sport: a new ally?” Journal of the European Academy of Dermatology and Venereology, vol. 29, no. 3, pp. 515–520, 2015. View at Publisher · View at Google Scholar
  67. É. Toussirot, F. Aubin, and G. Dumoulin, “Relationships between adipose tissue and psoriasis, with or without arthritis,” Frontiers in Immunology, vol. 5, article 368, 2014. View at Publisher · View at Google Scholar
  68. A. Yadav, P. Jyoti, S. K. Jain, and J. Bhattacharjee, “Correlation of adiponectin and leptin with insulin resistance: a pilot study in healthy North Indian population,” Indian Journal of Clinical Biochemistry, vol. 26, no. 2, pp. 193–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Yadav, M. A. Kataria, V. Saini, and A. Yadav, “Role of leptin and adiponectin in insulin resistance,” Clinica Chimica Acta, vol. 417, pp. 80–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. R. M. Abdel Hay and L. A. Rashed, “Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis,” Experimental Dermatology, vol. 20, no. 9, pp. 715–719, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Coimbra, H. Oliveira, F. Reis et al., “Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy,” Journal of the European Academy of Dermatology and Venereology, vol. 24, no. 12, pp. 1386–1394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. G. Fantuzzi, “Three questions about leptin and immunity,” Brain, Behavior, and Immunity, vol. 23, no. 4, pp. 405–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Matarese, S. Moschos, and C. S. Mantzoros, “Leptin in immunology,” The Journal of Immunology, vol. 174, no. 6, pp. 3137–3142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. S. A. Ismail and S. A. Mohamed, “Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity,” The British Journal of Dermatology, vol. 167, no. 2, pp. 436–439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Johnston, S. Arnadottir, J. E. Gudjonsson et al., “Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation,” British Journal of Dermatology, vol. 159, no. 2, pp. 342–350, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. D. Koczan, R. Guthke, H.-J. Thiesen et al., “Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules,” European Journal of Dermatology, vol. 15, no. 4, pp. 251–257, 2005. View at Google Scholar · View at Scopus
  77. E. Toussirot, D. Binda, C. Gueugnon, and G. Dumoulin, “Adiponectin in autoimmune diseases,” Current Medicinal Chemistry, vol. 19, no. 32, pp. 5474–5480, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. B. Gustafson, A. Hammarstedt, C. X. Andersson, and U. Smith, “Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2276–2283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Wakkee, H. B. Thio, E. P. Prens, E. J. G. Sijbrands, and H. A. M. Neumann, “Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients,” Atherosclerosis, vol. 190, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. J. E. Gudjonsson, A. Johnston, S. W. Stoll et al., “Evidence for altered wnt signaling in psoriatic skin,” Journal of Investigative Dermatology, vol. 130, no. 7, pp. 1849–1859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Gerdes, M. Laudes, K. Neumann, H. Baurecht, and U. Mrowietz, “Wnt5a—a potential factor linking psoriasis to metabolic complications,” Experimental Dermatology, vol. 23, no. 6, pp. 439–440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Y. Oh and J. M. Olefsky, “Wnt fans the flames in obesity,” Science, vol. 329, no. 5990, pp. 397–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. I. Grozdev, N. Korman, and N. Tsankov, “Psoriasis as a systemic disease,” Clinics in Dermatology, vol. 32, no. 3, pp. 343–350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. A. W. Armstrong, C. T. Harskamp, and E. J. Armstrong, “Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies,” Journal of the American Academy of Dermatology, vol. 68, no. 4, pp. 654–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. R. Pereira, S. T. Amladi, and P. K. Varthakavi, “A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis,” Indian Journal of Dermatology, vol. 56, no. 5, pp. 520–526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Rajappa, S. Rathika, M. Munisamy, L. Chandrashekar, and D. M. Thappa, “Effect of treatment with methotrexate and coal tar on adipokine levels and indices of insulin resistance and sensitivity in patients with psoriasis vulgaris,” Journal of the European Academy of Dermatology and Venereology, vol. 29, no. 1, pp. 69–76, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Boehncke, D. Thaci, H. Beschmann et al., “Psoriasis patients show signs of insulin resistance,” British Journal of Dermatology, vol. 157, no. 6, pp. 1249–1251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Gyldenløve, H. Storgaard, J. J. Holst, T. Vilsbøll, F. K. Knop, and L. Skov, “Patients with psoriasis are insulin resistant,” Journal of American Academy of Dermatology, vol. 72, no. 4, pp. 599–560, 2015. View at Publisher · View at Google Scholar
  89. F. Moro, C. de Simone, A. Morciano et al., “Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis,” Fertility and Sterility, vol. 99, no. 3, pp. 936–942, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Varani, N. Bhagavathula, C. N. Ellis, and H. A. Pershadsingh, “Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease,” Expert Opinion on Investigational Drugs, vol. 15, no. 11, pp. 1453–1468, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. C. N. Ellis, J. Varani, G. J. Fisher et al., “Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation,” Archives of Dermatology, vol. 136, no. 5, pp. 609–616, 2000. View at Google Scholar · View at Scopus
  92. N. Shafiq, S. Malhotra, P. Pandhi, M. Gupta, B. Kumar, and K. Sandhu, “Pilot trial: pioglitazone versus placebo in patients with plaque psoriasis (the P6),” International Journal of Dermatology, vol. 44, no. 4, pp. 328–333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Malhotra, N. Shafiq, S. Rajagopalan, S. Dogra, and S. Malhotra, “Thiazolidinediones for plaque psoriasis: a systematic review and meta-analysis,” Evidence-Based Medicine, vol. 17, no. 6, pp. 171–176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. V. G. Hafez, M. Bosseila, M. R. Abdel Halim, O. G. Shaker, M. Kamal, and H. S. Kareem, “Clinical effects of ‘pioglitazone’, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trialx1,” Journal of Dermatological Treatment, vol. 1, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  95. N. R. Trivedi, Z. Cong, A. M. Nelson et al., “Peroxisome proliferator-activated receptors increase human sebum production,” Journal of Investigative Dermatology, vol. 126, no. 9, pp. 2002–2009, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. R. Shah, A. Jindal, and N. M. Patel, “Acrochordons as a cutaneous sign of metabolic syndrome: a case-control study,” Annals of Medical and Health Sciences Research, vol. 4, no. 2, p. 202, 2014. View at Publisher · View at Google Scholar
  97. J. K. Agarwal and P. K. Nigam, “Acrochordon: a cutaneous sign of carbohydrate intolerance,” The Australasian Journal of Dermatology, vol. 28, no. 3, pp. 132–133, 1987. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Demir and Y. Demir, “Acrochordon and impaired carbohydrate metabolism,” Acta Diabetologica, vol. 39, no. 2, pp. 57–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Kahana, E. Grossman, A. Feinstein, M. Ronnen, M. Cohen, and M. S. Millet, “Skin tags: a cutaneous marker for diabetes mellitus,” Acta Dermato-Venereologica, vol. 67, no. 2, pp. 175–177, 1987. View at Google Scholar · View at Scopus
  100. N. S. Scheinfeld, “Obesity and dermatology,” Clinics in Dermatology, vol. 22, no. 4, pp. 303–309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. N. S. A. A. Fattah and Y. W. Darwish, “Androgenetic alopecia and insulin resistance: are they truly associated?” International Journal of Dermatology, vol. 50, no. 4, pp. 417–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. G. Severi, R. Sinclair, J. L. Hopper et al., “Androgenetic alopecia in men aged 40–69 years: prevalence and risk factors,” The British Journal of Dermatology, vol. 149, no. 6, pp. 1207–1213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. B. O. Yildiz, “Diagnosis of hyperandrogenism: clinical criteria,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 20, no. 2, pp. 167–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. L. Nabaie, S. Kavand, R. M. Robati, N. Sarrafi-Rad, L. Shahgholi, and G. Meshkat-Razavi, “Androgenic alopecia and insulin resistance: are they really related?” Clinical and Experimental Dermatology, vol. 34, no. 6, pp. 694–697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. V. A. Matilainen, P. Koskela, and S. Keinänen-Kiukaanniemi, “Early androgenetic alopecia as a marker of insulin resistance,” The Lancet, vol. 356, no. 9236, pp. 1165–1166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. O. Bakry, M. A. Shoeib, M. El Shafiee, and A. Hassan, “Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case-control study,” Indian Dermatology Online Journal, vol. 5, no. 3, pp. 276–281, 2014. View at Publisher · View at Google Scholar
  107. J. G. González-González, L. G. Mancillas-Adame, M. Fernández-Reyes et al., “Androgenetic alopecia and insulin resistance in young men,” Clinical Endocrinology, vol. 71, no. 4, pp. 494–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Mumcuoglu, T. R. Ekmekci, and S. Ucak, “The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia,” European Journal of Dermatology, vol. 21, no. 1, pp. 79–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. P. Hirsso, U. Rajala, L. Hiltunen et al., “Association of low-insulin sensitivity measured by quantitative insulin sensitivity check index with hair loss in 55-year-old men. A Finnish population-based study,” Diabetes, Obesity and Metabolism, vol. 8, no. 4, pp. 466–468, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Horton, V. Pasupuletti, and I. Antonipillai, “Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-I,” Endocrinology, vol. 133, no. 2, pp. 447–451, 1993. View at Publisher · View at Google Scholar · View at Scopus
  111. C. Dessinioti, A. Katsambas, and C. Antoniou, “Hidradenitis suppurrativa (acne inversa) as a systemic disease,” Clinics in Dermatology, vol. 32, no. 3, pp. 397–408, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. G. B. E. Jemec, “Clinical practice. Hidradenitis suppurativa,” The New England Journal of Medicine, vol. 366, no. 2, pp. 158–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. H. Kurzen, I. Kurokawa, G. B. E. Jemec et al., “What causes hidradenitis suppurativa?” Experimental Dermatology, vol. 17, no. 5, pp. 455–456, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. B. J. Harrison, G. F. Read, and L. E. Hughes, “Endocrine basis for the clinical presentation of hidradenitis suppurativa,” British Journal of Surgery, vol. 75, no. 10, pp. 972–975, 1988. View at Publisher · View at Google Scholar · View at Scopus
  115. R. L. Rosenfield, “Hirsutism,” The New England Journal of Medicine, vol. 353, no. 24, pp. 2578–2588, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. R. Azziz, E. Carmina, and M. E. Sawaya, “Idiopathic hirsutism,” Endocrine Reviews, vol. 21, no. 4, pp. 347–362, 2000. View at Publisher · View at Google Scholar · View at Scopus
  117. K. Ünlühizarci, Y. Karababa, F. Bayram, and F. Kelestimur, “The investigation of insulin resistance in patients with idiopathic hirsutism,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 6, pp. 2741–2744, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. N. S. Abdel Fattah and Y. W. Darwish, “Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?” The British Journal of Dermatology, vol. 160, no. 5, pp. 1011–1015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. K. A. Seetharam, “Alopecia areata: an update,” Indian Journal of Dermatology, Venereology and Leprology, vol. 79, no. 5, pp. 563–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. S. A. Muller and R. K. Winkelmann, “Alopecia areata. An evaluation of 736 patients,” Archives of Dermatology, vol. 88, no. 3, pp. 290–297, 1963. View at Publisher · View at Google Scholar · View at Scopus
  121. A. S. Karadag, D. T. Ertugrul, S. G. Bilgili, Z. Takci, E. Tutal, and H. Yilmaz, “Insulin resistance is increased in alopecia areata patients,” Cutaneous and Ocular Toxicology, vol. 32, no. 2, pp. 102–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. J. Akrem, A. Baroudi, T. Aichi, F. Houch, and M. H. Hamdaoui, “Profile of vitiligo in the south of Tunisia,” International Journal of Dermatology, vol. 47, no. 7, pp. 670–674, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. A. S. Karadag, E. Tutal, and D. T. Ertugrul, “Insulin resistance is increased in patients with vitiligo,” Acta Dermato-Venereologica, vol. 91, no. 5, pp. 541–544, 2011. View at Publisher · View at Google Scholar · View at Scopus